← Back to headlines
Praxis Stock Surges 320% Following Biotech Investor's Substantial Buy
Praxis Precision Medicines' stock experienced a dramatic 320% surge after a single biotech investor increased their stake to nearly $600 million.
22 Feb, 19:36 — 22 Feb, 19:36
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
MoCI and Hassad Food Sign Agreement to Manage Central Markets in Qatar
15m ago
China Becomes Germany's Largest Trading Partner
15m ago
Tariff Ruling Sends CEOs Back to Company War Rooms - The Wall Street Journal
19m ago
American Airlines Says Due To Ongoing Situation In Puerto Vallarta (PVR) & Guadalajara (GDL), Co Canceled Flights To & From PVR & GDL For Remainder Of Feb 22 - TradingView
19m ago